NASDAQ:COCO • US92846Q1076
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VITA COCO CO INC/THE (COCO).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-24 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-19 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-01-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-25 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-11-24 | Stephens & Co. | Upgrade | Equal-Weight -> Overweight |
| 2025-11-18 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-11-17 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-11-17 | B of A Securities | Upgrade | Neutral -> Buy |
| 2025-11-17 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-17 | Jefferies | Maintains | Buy -> Buy |
| 2025-10-30 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-30 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-30 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-08 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-10-02 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-09-25 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-09-25 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-09-24 | Needham | Initiate | Hold |
| 2025-08-20 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2025-07-31 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-07-31 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-30 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-01 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-03-27 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2025-02-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 493.612M 15.38% | 516.013M 4.54% | 609.78M 18.17% | 694.76M 13.94% | 778.5M 12.05% | 874.14M 12.29% | 964.92M 10.39% | 1.057B 9.54% | 1.056B -0.09% | 1.146B 8.52% | |
| EBITDA YoY % growth | 57.153M 364.66% | 74.565M 30.47% | 83.604M 12.12% | 129.36M 54.73% | 150.69M 16.49% | 173.22M 14.95% | 201.96M 16.59% | 222.36M 10.10% | 201.96M -9.17% | 219.3M 8.59% | |
| EBIT YoY % growth | 56.493M 443.20% | 73.82M 30.67% | 82.532M 11.80% | 117.27M 42.09% | 138.86M 18.41% | 156.92M 13.01% | 182.58M 16.35% | 201.96M 10.61% | 181.56M -10.10% | 197.88M 8.99% | |
| Operating Margin | 11.44% | 14.31% | 13.53% | 16.88% | 17.84% | 17.95% | 18.92% | 19.11% | 17.19% | 17.27% | |
| EPS YoY % growth | 0.80 471.43% | 0.94 17.50% | 1.18 25.53% | 1.56 31.97% | 1.84 18.28% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.32 3.78% | 0.51 34.85% | 0.49 23.60% | 0.21 138.00% | 0.40 24.82% | 0.57 11.40% | 0.58 16.36% | 0.23 5.87% |
| Revenue Q2Q % growth | 150.36M 14.85% | 200.13M 18.59% | 202.81M 11.24% | 139.15M 8.89% | 174.99M 16.38% | 225.6M 12.73% | 235.73M 16.23% | 159.31M 14.49% |
| EBITDA Q2Q % growth | 25.901M 32.86% | 40.782M 59.74% | 37.206M 30.28% | 16.046M 42.43% | 34.017M 31.33% | 46.206M 13.30% | 48.501M 30.36% | 21.114M 31.58% |
| EBIT Q2Q % growth | 23.431M 21.45% | 38.155M 51.88% | 33.076M 18.45% | 12.692M 24.50% | 32.436M 38.43% | 46.308M 21.37% | 48.552M 46.79% | 19.278M 51.89% |
All data in USD
17 analysts have analysed COCO and the average price target is 62.11 USD. This implies a price increase of 20.08% is expected in the next year compared to the current price of 51.72.
The consensus EPS estimate for the next earnings of VITA COCO CO INC/THE (COCO) is 0.32 USD and the consensus revenue estimate is 150.36M USD.
The expected long term growth rate for VITA COCO CO INC/THE (COCO) is 12.68%.